20
NPS Score
VS
Gilead Sciences Claimed Company
- EMPLOYEE
PARTICIPANTS - 210
- TOTAL
RATINGS
NGM Biopharmaceuticals Claimed Company
- EMPLOYEE
PARTICIPANTS - 10
- TOTAL
RATINGS
Gilead Sciences vs NGM Biopharmaceuticals
Compare Gilead Sciences versus NGM Biopharmaceuticals for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 210 employees and customers of Gilead Sciences and 10 employees and customers of NGM Biopharmaceuticals.
Gilead Sciences
Gilead Sciences's brand is ranked #478 in the list of Global Top 1000 Brands, as rated by customers of Gilead Sciences. Their current market cap is $83.65B.
NGM Biopharmaceuticals
NGM Biopharmaceuticals's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of NGM Biopharmaceuticals. Their current market cap is $280.84M.
3.8/5
Product Quality
3.2/5
3.6/5
Pricing
4.1/5
3.9/5
Customer Service
5/5
| 50% | Promoters |
|---|---|
| 20% | Passive |
| 30% | Detractors |
20
NPS Score
| 60% | Promoters |
|---|---|
| 0% | Passive |
| 40% | Detractors |
Working at Gilead Sciences vs Working at NGM Biopharmaceuticals
68 / 100
CEO Rating
86 / 100
CEO Rating
Winner by 18%
Gilead Sciences
Gilead Sciences doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
NGM Biopharmaceuticals
Employees at NGM Biopharmaceuticals rate their CEO, David Woodhouse, 86/100. This score is 18% higher than the scores of Gilead Sciences' CEO, Daniel O’Day.